Financial Gravity Asset Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15
| Closed | -$212 | – | 1984 |
|
|
2024
Q1 | $212 | Buy |
15
+12
| +400% | +$170 | ﹤0.01% | 1609 |
|
|
2023
Q4 | $17 | Buy |
3
+2
| +200% | +$11 | ﹤0.01% | 1441 |
|
|
2023
Q3 | $7 | Buy |
+1
| New | +$7 | ﹤0.01% | 1183 |
|
|
2023
Q2 | – | Hold |
0
| – | -$15 | – | 1501 |
|
|
2023
Q1 | – | Hold |
0
| – | -$60 | – | 822 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | -$31 | – | 1198 |
|
|
2022
Q3 | $31 | Hold |
1
| – | – | ﹤0.01% | 685 |
|
|
2022
Q2 | $31 | Sell |
1
-1
| -50% | -$31 | ﹤0.01% | 632 |
|
|
2022
Q1 | $64 | Sell |
2
-1
| -33% | -$32 | ﹤0.01% | 636 |
|
|
2021
Q4 | $88 | Buy |
3
+1
| +50% | +$29 | ﹤0.01% | 678 |
|
|
2021
Q3 | $7K | Buy |
+2
| New | +$7K | ﹤0.01% | 920 |
|
|
2020
Q2 | – | Sell |
-1
| Closed | -$67 | – | 437 |
|
|
2020
Q1 | $67 | Sell |
1
-2
| -67% | -$134 | ﹤0.01% | 935 |
|
|
2019
Q4 | $3K | Hold |
3
| – | – | ﹤0.01% | 1312 |
|
|
2019
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 1395 |
|
|
2019
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 1450 |
|
|
2019
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1433 |
|
|
2018
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1509 |
|